Journal of vascular surgery. Venous and lymphatic disorders · 2026
Laparoscopic and robotic extravascular stenting of the left renal vein for anterior nutcracker syndrome in a single-center series.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang Shuai, Li Kai, Chang Fan, Li Song, Lv Zheng, Zhang Jianghui, Wu Wensong, Shi Huiyuan, Chen Fangmin
Аннотация
BACKGROUND: Nutcracker syndrome (NCS) arises from extrinsic compression of the left renal vein (LRV) between the superior mesenteric artery and the abdominal aorta. Extravascular stenting (EVS) has emerged as a minimally invasive alternative to historical operations and endovascular stents. We report a single-center series spanning 2010 to 2025 and propose a standardized, reproducible framework that couples intraoperative process quality with objective postoperative hemodynamic targets.
METHODS: We retrospectively analyzed 22 consecutive NCS patients treated with laparoscopic or robot-assisted EVS. We standardized five intraoperative steps (five-in-a-row: fibrotic-ring resection, proper length tailoring/placement, sufficient superior mesenteric artery mobilization, complete division of LRV tributaries, stable anterior fixation). Postoperative duplex ultrasound metrics included aortomesenteric (AM) LRV peak systolic velocity and the AM/hilum peak systolic velocity (PSV) ratio. Thresholds were determined by receiver operating characteristic-Youden index; performance was summarized at fixed cutoffs, with bootstrap for the ratio and exploratory OR/AND combinations.
RESULTS: Complete success was achieved in 18 of 22 patients (81.8%). Data-driven analysis identified a postoperative AM PSV of ≤72 cm/s as the primary attainment threshold, yielding a sensitivity of 1.00, specificity of 0.75, accuracy of 0.95, and area under the receiver operating characteristic curve (AUC) of ≈0.917. The AM/hilum ratio showed a Youden-optimal cutoff of ≈1.90 (clinically ≈2.0) with an AUC of ≈0.56, supporting its role as a sensitivity/replicability metric rather than a standalone gatekeeper. OR and AND combinations demonstrated expected trade-offs; a simple 0/1/2 composite score achieved an AUC of ≈0.78. The five-in-a-row checklist was concordant with attaining the AM-PSV target on Doppler ultrasound examination.
CONCLUSIONS: Laparoscopic or robot-assisted EVS is a safe, feasible, and effective option for NCS. We a propose postoperative AM PSV of ≤72 cm/s as a unified, reproducible primary quantitative end point, with an AM/hilum ratio of ≈2.0 as a secondary, replicability-oriented metric. Integrating these targets with a standardized five-in-a-row checklist establishes a process-outcome loop that enhances procedural reproducibility and supports sustained symptom relief over the available follow-up.
METHODS: We retrospectively analyzed 22 consecutive NCS patients treated with laparoscopic or robot-assisted EVS. We standardized five intraoperative steps (five-in-a-row: fibrotic-ring resection, proper length tailoring/placement, sufficient superior mesenteric artery mobilization, complete division of LRV tributaries, stable anterior fixation). Postoperative duplex ultrasound metrics included aortomesenteric (AM) LRV peak systolic velocity and the AM/hilum peak systolic velocity (PSV) ratio. Thresholds were determined by receiver operating characteristic-Youden index; performance was summarized at fixed cutoffs, with bootstrap for the ratio and exploratory OR/AND combinations.
RESULTS: Complete success was achieved in 18 of 22 patients (81.8%). Data-driven analysis identified a postoperative AM PSV of ≤72 cm/s as the primary attainment threshold, yielding a sensitivity of 1.00, specificity of 0.75, accuracy of 0.95, and area under the receiver operating characteristic curve (AUC) of ≈0.917. The AM/hilum ratio showed a Youden-optimal cutoff of ≈1.90 (clinically ≈2.0) with an AUC of ≈0.56, supporting its role as a sensitivity/replicability metric rather than a standalone gatekeeper. OR and AND combinations demonstrated expected trade-offs; a simple 0/1/2 composite score achieved an AUC of ≈0.78. The five-in-a-row checklist was concordant with attaining the AM-PSV target on Doppler ultrasound examination.
CONCLUSIONS: Laparoscopic or robot-assisted EVS is a safe, feasible, and effective option for NCS. We a propose postoperative AM PSV of ≤72 cm/s as a unified, reproducible primary quantitative end point, with an AM/hilum ratio of ≈2.0 as a secondary, replicability-oriented metric. Integrating these targets with a standardized five-in-a-row checklist establishes a process-outcome loop that enhances procedural reproducibility and supports sustained symptom relief over the available follow-up.